Informed Consent for Low-Dose Atropine Therapy for Eye Floaters
Purpose and Mechanism of Action
This informed consent outlines the off-label use of low-dose atropine sulfate ophthalmic solution (typically concentrations ranging from $0.005\%$ to $0.01\%$) to manage and reduce the symptomatic impact of eye floaters. Atropine works by temporarily and mildly dilating the pupil (mydriasis) and relaxing the focusing muscle of the eye (cycloplegia). By slightly widening the pupil, light can more easily bend around vitreous opacities, diffusing the shadows they cast onto your retina. While this treatment does not physically dissolve or remove the floaters from the vitreous gel, it aims to make them significantly less noticeable and improve your overall visual comfort.
Potential Risks, Side Effects, and Alternatives
While low-dose atropine is generally well-tolerated, potential side effects include mild light sensitivity (photophobia) due to increased pupil size, temporary blurring of near vision, and minor eye irritation or dryness. These effects are usually concentration-dependent and minimize over time. Rare systemic effects, though highly unlikely at low doses, can include dry mouth or an increased heart rate. You should not use this medication if you have a history of narrow-angle glaucoma. Alternative options for managing eye floaters include observation (allowing your brain to naturally adapt over time through neuroadaptation), a surgical vitrectomy, or Nd:YAG laser vitreolysis. Each alternative carries its own distinct set of risks and success rates that should be thoroughly discussed with your eye care professional.
Acknowledgement and Consent
By submitting this form, I acknowledge that I have read and understood the information provided regarding low-dose atropine therapy for eye floaters. I have had the opportunity to ask questions, and all my inquiries have been answered to my satisfaction. I understand that this treatment is an off-label use of the medication, intended for symptom management rather than a physical cure. I agree to attend all recommended follow-up appointments to monitor my eye pressure and overall ocular health, and I understand I can discontinue the treatment at any time.
